(Q39061079)

8 September 2017

title

Attenuation of β-amyloid-induced tauopathy via activation of CK2α/SIRT1: targeting for cilostazol (English)

1 reference

8 September 2017

1 reference

Hye Rin Lee

1

1 reference

8 September 2017

Hwa Kyoung Shin

2

1 reference

8 September 2017

So Youn Park

3

1 reference

8 September 2017

Hye Young Kim

4

1 reference

8 September 2017

Won Suk Lee

5

1 reference

8 September 2017

Byung Yong Rhim

6

1 reference

8 September 2017

Ki Whan Hong

7

1 reference

8 September 2017

Chi Dae Kim

8

1 reference

8 September 2017

publication date

19 November 2013

1 reference

Journal of Neuroscience Research

8 September 2017

published in

1 reference

8 September 2017

volume

92

1 reference

8 September 2017

issue

2

1 reference

8 September 2017

page(s)

206-217

1 reference

Neuronal protection by sirtuins in Alzheimer's disease

8 September 2017

cites work

1 reference

Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration

21 January 2018

1 reference

Role of tau protein in both physiological and pathological conditions.

21 January 2018

1 reference

Tau-mediated neurodegeneration in Alzheimer's disease and related disorders

21 January 2018

1 reference

The CBP co-activator is a histone acetyltransferase

21 January 2018

1 reference

Virtual ligand screening of the p300/CBP histone acetyltransferase: identification of a selective small molecule inhibitor

21 January 2018

1 reference

The acetylation of tau inhibits its function and promotes pathological tau aggregation

21 January 2018

1 reference

A role for neuronal cAMP responsive-element binding (CREB)-1 in brain responses to calorie restriction

21 January 2018

1 reference

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

21 January 2018

1 reference

Cilostazol prevents amyloid β peptide25‐35‐induced memory impairment and oxidative stress in mice

21 January 2018

1 reference

The GSK3 hypothesis of Alzheimer's disease

21 January 2018

1 reference

Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan

21 January 2018

1 reference

The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation

21 January 2018

1 reference

Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease

21 January 2018

1 reference

Repeat motifs of tau bind to the insides of microtubules in the absence of taxol

21 January 2018

1 reference

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease

21 January 2018

1 reference

Protection by cilostazol against amyloid-β(1-40)-induced suppression of viability and neurite elongation through activation of CK2α in HT22 mouse hippocampal cells

21 January 2018

1 reference

Disruption of CREB function in brain leads to neurodegeneration

21 January 2018

1 reference

First non-ATP competitive glycogen synthase kinase 3 beta (GSK-3beta) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease

21 January 2018

1 reference

Acetylation of tau inhibits its degradation and contributes to tauopathy

21 January 2018

1 reference

CREB and ChREBP oppositely regulate SIRT1 expression in response to energy availability

21 January 2018

1 reference

Therapeutic role of sirtuins in neurodegenerative disease.

21 January 2018

1 reference

Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation

21 January 2018

1 reference

Mitogen inactivation of glycogen synthase kinase-3 beta in intact cells via serine 9 phosphorylation

21 January 2018

1 reference

Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signaling

21 January 2018

1 reference

Tetrabromocinnamic Acid (TBCA) and Related Compounds Represent a New Class of Specific Protein Kinase CK2 Inhibitors

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/JNR.23310

1 reference

8 September 2017

1 reference